We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+5.71%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.44B
AUM Growth
+$635M
(+13%)
Cap. Flow
+$416M
Cap. Flow
% of AUM
7.65%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
579
New
166
Increased
105
Reduced
70
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$66.9M |
| 2 |
Crown Castle
CCI
|
+$53.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$52M |
| 4 |
CCI.PRA
Crown Castle International Corp.
CCI.PRA
|
+$48.4M |
| 5 |
Dollar Tree
DLTR
|
+$42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$60.5M |
| 2 |
Colgate-Palmolive
CL
|
+$46.1M |
| 3 |
ELN
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
|
+$44.4M |
| 4 |
Walmart Inc
WMT
|
+$41.7M |
| 5 |
Macy's
M
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 17.07% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 7.66% |
| 4 | Financials | 6.61% |
| 5 | Consumer Discretionary | 6.34% |
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q4 2013 Portfolio in Review
As of Q4 2013, UBS O'Connor held 579 positions worth $5.44B, up 13% from $4.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS O'Connor deployed $416M of net new capital in Q4 2013, opening 166 new positions and adding to 105 existing holdings. Its largest new stake was American Airlines Group: 2,596,600 shares worth $65.6M.
By sector, the portfolio is most concentrated in Real Estate at 17% of assets, up from 15% a quarter earlier, followed by Consumer Staples and Industrials.
On the sell side, the largest reduction was Colgate-Palmolive, an estimated $46.1M trimmed.
- UBS O'Connor's largest Q4 2013 buy was American Airlines Group: 2,596,600 shares worth $65.6M.
- UBS O'Connor added most to Crown Castle in Q4 2013, an estimated $53.8M increase.
- UBS O'Connor's biggest Q4 2013 reduction was Colgate-Palmolive, cutting an estimated $46.1M.
- UBS O'Connor fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $60.5M.
- UBS O'Connor's ten largest holdings make up 16% of its $5.44B portfolio in Q4 2013.
- UBS O'Connor opened 166 new positions and closed 180 in Q4 2013.
- UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $5.44B.
Based on UBS O'Connor's 13F filing for Q4 2013, filed 13 Feb 2014.